Virulence of pneumococcal proteins on the inner ear

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 7, 2009, Pages 657-661

  Schachern, Patricia A ^a,d   Tsuprun, Vladimir ^a   Cureoglu, Sebahattin ^a   Ferrieri, Patricia ^b   Briles, David E ^c   Paparella, Michael M ^a   Juhn, Steven ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c University of Alabama at Birmingham   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PNEUMOCOCCAL SURFACE ANTIGEN A; PNEUMOCOCCAL SURFACE PROTEIN A; PNEUMOLYSIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHINCHILLA; COCHLEA FENESTRA; CONTROLLED STUDY; EAR INJURY; INFLAMMATORY CELL; INNER EAR; INOCULATION; MUTATION; NONHUMAN; OTITIS MEDIA; PATHOLOGY; STREPTOCOCCUS PNEUMONIAE; TISSUE SECTION; VIRULENCE; WILD TYPE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHINCHILLA; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; ROUND WINDOW, EAR; STREPTOCOCCUS PNEUMONIAE; VIRULENCE;

EID: 67651108741     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.72     Document Type: Article

References (28)

1. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160(1):83-94. (Pubitemid 19162997)
2. Bergus GR, Levy SM, Kirchner HL, Warren JJ, Levy BT. A prospective study of antibiotic use and associated infections in young children. Paediatr Perinat Epidemiol. 2001;15(1):61-67. (Pubitemid 32155758)
3. McClay JE. Resistant bacteria in the adenoids: a preliminary report. Arch Otolaryngol Head Neck Surg. 2000;126(5):625-629.
4. Zapalac JS, Billings KR, Schwade ND, Roland PS. Suppurative complications of acute otitis media in the era of antibiotic resistance. Arch Otolaryngol Head Neck Surg. 2002;128(6):660-663. (Pubitemid 34665847)
5. Redaelli de Zinis LO, Campovecchi C, Parrinello G, Antonelli AR. Predisposing factors for inner ear hearing loss association with chronic otitis media. Int J Audiol. 2005;44(10):593-598. (Pubitemid 41608206)
6. Paton JC. Novel pneumococcal surface proteins: role in virulence and vaccine potential. Trends Microbiol. 1998;6(3):85-87.
7. Schachern P, Tsuprun V, Cureoglu C, et al. The round window membrane in otitis media: effect of pneumococcal proteins. Arch Otolaryngol Head Neck Surg. 2008;134(6):658-662. (Pubitemid 351871029)
8. Schachern PA, Paparella MM, Hybertson R, Sano S, Duvall AJ III. Bacterial tympanogenic labyrinthitis, meningitis, and sensorineural damage. Arch Otolaryngol Head Neck Surg. 1992;118(1):53-57.
9. Hunter LL, Margolis RH, Rykken JR, Le CT, Daly KA, Giebink GS. High frequency hearing loss associated with otitis media. Ear Hear. 1996;17(1):1-11. (Pubitemid 26043699)
10. Cureoglu S, Schachern PA, Paparella MM, Lindgren BR. Cochlear changes in chronic otitis media. Laryngoscope. 2004;114(4):622-626. (Pubitemid 38548770)
11. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30(1):100-121. (Pubitemid 30067069)
12. Roche AM, King SJ, Weiser JN. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect Immun. 2007;75(5):2469-2475.
13. Tu AH, Fulgham RL, McCrory MA, Briles DE, Szalai AJ. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infect Immun. 1999;67(9):4720-4724.
14. Ren B, Szalai AJ, Hollingshead SK, Briles DE. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect Immun. 2004;72(1):114-122. (Pubitemid 38018168)
15. Dintilhac A, Alloing G, Granadel C, Claverys JP. Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases. Mol Microbiol. 1997;25(4):727-739. (Pubitemid 27394570)
16. Sato K, Quartey MK, Liebeler CL, Le CT, Giebink GS. Roles of autolysin and pneumolsin in middle ear inflammation caused by a type 3 streptococcus pneumoniae strain in the chinchilla otitis media model. Infect Immun. 1996;64(4):1140-1145. (Pubitemid 26104610)
17. Jedrzejas MJ. Unveiling molecular mechanisms of pneumococcal surface protein A interaction with antibodies and lactoferrin. Clin Chim Acta. 2006;367(1-2):1-10.
18. Giebink GS, Carlson BA, Hetherington SV, Hostetter MK, Le CT, Juhn SK. Bacterial and polymorphonuclear leukocyte contribution to middle ear inflammation in chronic otitis media with effusion. Ann Otol Rhinol Laryngol. 1985;94(4, pt 1):398-402.
19. Wu HY, Nahm MH, Guo Y, Russell MW, Briles DE. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis. 1997;175(4):839-846. (Pubitemid 27142957)
20. Moscoso M, Garcia E, Lopez R. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol. 2006;188(22):7785-7795. (Pubitemid 44764515)
21. Crain MJ, Waltman WD II, Turner JS, et al. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect Immun. 1990;58(10):3293-3299.
22. Palaniappan R, Singh S, Singh UP, et al. Differential PsaA-, PspA-, PspC-, and Pdb-specific immune responses in a mouse model of pneumococcal carriage. Infect Immun. 2005;73(2):1006-1013. (Pubitemid 40165761)
23. Nabors GS, Braun PA, Herrmann DJ, et al. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine. 2000;18(17):1743-1754.
24. Briles DE, Hollingshead S, Brooks WA, et al. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine. 2000;18(16):1701-1711.
25. Arulanandam BP, Lynch JM, Briles DE, Hollingshead S, Metzger DW. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect Immun. 2001;69(11):6718-6724.
26. Tuomanen E. Molecular and cellular biology of pneumococcal infection. Curr Opin Microbiol. 1999;2(1):35-39. (Pubitemid 29130212)
27. Briles DE, Ades E, Paton JC, et al. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun. 2000;68(2):796-800.
28. Romero-Steiner S, Caba J, Rajam G, et al. Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-coated particles to human nasopharyngeal epithelial cells for the evaluation of anti-PsaA functional antibodies. Vaccine. 2006;24(16):3224-3231.